{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:56:04Z","timestamp":1790848564612,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG087210"],"award-info":[{"award-number":["RF1AG087210"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG077620"],"award-info":[{"award-number":["R01AG077620"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG089541"],"award-info":[{"award-number":["RF1AG089541"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jamda.2026.106417","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:33:37Z","timestamp":1786466017000},"page":"106417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-Drug Interactions in Nursing Home Residents With vs Without Dementia"],"prefix":"10.1016","volume":"27","author":[{"given":"Mallory","family":"Go","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori. A.","family":"Daiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1122-0071","authenticated-orcid":false,"given":"Kaleen N.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2026.106417_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1472932","article-title":"Patients with dementia: prevalence and type of drug\u2013drug interactions","volume":"15","author":"Mu\u00f1oz-Contreras","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jamda.2026.106417_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1017\/S1041610220004032","article-title":"Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis","volume":"33","author":"Jester","year":"2021","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2026.106417_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jagp.2024.09.005","article-title":"Trends in hyperpolypharmacy before and after nursing home admission among older adults in Ontario, Canada","volume":"33","author":"Maclagan","year":"2025","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2026.106417_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.22505","article-title":"Effectiveness of bundled hyperpolypharmacy deprescribing compared with usual care among older adults: a randomized clinical trial","volume":"6","author":"Herrinton","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jamda.2026.106417_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","volume":"12","author":"Zazzara","year":"2021","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jamda.2026.106417_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/17425255.2017.1325873","article-title":"Pharmacokinetic and pharmacodynamic alterations in older people with dementia","volume":"13","author":"Reeve","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jamda.2026.106417_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2018.04.009","article-title":"Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics","volume":"135","author":"Pan","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jamda.2026.106417_bib9","series-title":"StatPearls","article-title":"Polypharmacy","author":"Varghese","year":"2025"},{"key":"10.1016\/j.jamda.2026.106417_bib10","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s41999-023-00872-0","article-title":"Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy: EuGMS SIG on pharmacology position paper","volume":"14","author":"van Poelgeest","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jamda.2026.106417_bib12","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1111\/jgs.70175","article-title":"Prevalence and duration of potential drug-drug interactions among US nursing home residents, 2018-2020","volume":"73","author":"Reich","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106417_bib13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/aje\/kwaf227","article-title":"Identifying observable medication use time in administrative databases: a tutorial using nursing home residents","volume":"195","author":"Harris","year":"2026","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jamda.2026.106417_bib14","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.jamda.2021.03.019","article-title":"An international consensus list of potentially clinically significant drug-drug interactions in older people","volume":"22","author":"Anrys","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106417_bib15","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106417_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11096-022-01511-7","article-title":"Drug-drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care","volume":"45","author":"Capiau","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jamda.2026.106417_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029865","article-title":"Benefits and harms of standard versus reduced-dose direct oral anticoagulant therapy for older adults with multiple morbidities and atrial fibrillation","volume":"12","author":"Hayes","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jamda.2026.106417_bib19","first-page":"27","article-title":"More accurate racial and ethnic codes for Medicare administrative data","volume":"29","author":"Eicheldinger","year":"2008","journal-title":"Health Care Financ Rev"},{"key":"10.1016\/j.jamda.2026.106417_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"Gagne","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jamda.2026.106417_bib21","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/MLR.0000000000000334","article-title":"The minimum data set 3.0 cognitive function scale","volume":"55","author":"Thomas","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2026.106417_bib22","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jamda.2026.106417_bib23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s40266-021-00898-8","article-title":"Prevalence and factors associated with potential drug-drug interactions in older community-dwelling adults: a prospective cohort study","volume":"38","author":"Hughes","year":"2021","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106417_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MLR.0000000000001577","article-title":"Dementia diagnosis disparities by race and ethnicity","volume":"59","author":"Lin","year":"2021","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2026.106417_bib26","series-title":"Prevalence and Duration of Potential Drug-Drug Interactions Among US Nursing Home Residents, 2018\u20132020","author":"Reich","year":"2025"},{"key":"10.1016\/j.jamda.2026.106417_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jgs.19256","article-title":"Clinician contributions to central nervous system-active polypharmacy among older adults with dementia in the United States","volume":"73","author":"Vordenberg","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106417_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13195-024-01405-y","article-title":"Prevalence and trend of central nervous system\u2013active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study","volume":"16","author":"Wei","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jamda.2026.106417_bib30","series-title":"StatPearls","article-title":"Geriatric cognitive decline and polypharmacy","author":"Chippa","year":"2025"},{"key":"10.1016\/j.jamda.2026.106417_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.archger.2015.10.002","article-title":"Systematic review on the use of anticholinergic scales in poly pathological patients","volume":"62","author":"Villalba-Moreno","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jamda.2026.106417_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/20420986211012592","article-title":"Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes","volume":"12","author":"Herrero-Zazo","year":"2021","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jamda.2026.106417_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jppr.1303","article-title":"Anticholinergic burden: considerations for older adults","volume":"47","author":"Kouladjian O'Donnell","year":"2017","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.jamda.2026.106417_bib34","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fnins.2019.01309","article-title":"Anticholinergic drugs in geriatric psychopharmacology","volume":"13","author":"L\u00f3pez-\u00c1lvarez","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jamda.2026.106417_bib35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4274\/ejgg.galenos.2024.2024-10-2","article-title":"The impact of anticholinergic burden on geriatric syndromes: screening in community-dwelling older adults","volume":"7","author":"S\u00fcrmeli","year":"2025","journal-title":"Eur J Geriatr Gerontol"},{"key":"10.1016\/j.jamda.2026.106417_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40266-018-0623-6","article-title":"Approaches to deprescribing psychotropic medications for changed behaviours in long-term care residents living with dementia","volume":"36","author":"Harrison","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106417_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000488483","article-title":"The link between potassium and mild cognitive impairment in Mexican-Americans","volume":"8","author":"Vintimilla","year":"2018","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.jamda.2026.106417_bib39","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/jgs.19019","article-title":"A comparison of dementia diagnoses and cognitive function measures in Medicare claims and the minimum data set","volume":"72","author":"Niznik","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106417_bib40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/gerona\/glab373","article-title":"Validation of claims algorithms to identify Alzheimer's disease and related dementias","volume":"77","author":"McCarthy","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026003075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026003075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:12:27Z","timestamp":1790845947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861026003075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1525861026003075"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106417","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Drug Interactions in Nursing Home Residents With vs Without Dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"106417"}}